Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas System”
1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 6060582
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
expired -
US 6054442
Methods and compositions for modulation and inhibition of telomerase in vitro
expired -
US 6051230
Compositions for targeting the vasculature of solid tumors
expired -
US 6051232
Chimeric MHC class I antigens for inducing allograft tolerance
expired -
US 6048534
Methods and compositions for the selective regulation of chorionic prostanoids
expired -
US 6046158
Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof
expired -
US 6045815
Parenteral pimaricin as treatment of systemic infections
expired -
US 6042846
Liposomal phosphodiester, phosphorothioate, and p-ethoxy oligonucleotides
expired -
US 6036955
Kits and methods for the specific coagulation of vasculature
expired -
US 6027888
Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells
expired -
US 6020154
H. influenzae HxuB and HxuC genes, proteins and methods of use
expired -
US 6017524
Inhibiting the growth p53 deficient tumor cells by administering the p53 gene
expired -
US 6017962
Method of depletion of methionine in plasma and solid tumors and uses thereof
expired -
US 6015811
Antitumor Chrysene derivatives
expired